May 12, 2020 / 10:02 PM / 20 days ago

BRIEF-Kempharm Reports Q1 Loss Per Share Of $0.12

May 12 (Reuters) - KemPharm Inc:

* Q1 LOSS PER SHARE $0.12

* KEMPHARM - BASED ON CURRENT OPERATING FORECAST, EXPECTED REVENUE AND EXISTING RESOURCES ARE SUFFICIENT TO CONTINUE OPERATIONS INTO, BUT NOT THROUGH MARCH 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below